17beta-estradiol increases expression ISO RGD:737053 6480464 Estradiol results in increased expression of AMOTL2 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737054 6480464 Tetrachlorodibenzodioxin affects the expression of AMOTL2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AMOTL2 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737054 6480464 Tetrachlorodibenzodioxin results in decreased expression of AMOTL2 mRNA CTD PMID:15034205 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:737054 6480464 tetrabromobisphenol A results in decreased expression of AMOTL2 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737053 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AMOTL2 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide decreases expression ISO RGD:737054 6480464 Fenretinide results in decreased expression of AMOTL2 mRNA CTD PMID:28973697 acrolein multiple interactions ISO RGD:737053 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of AMOTL2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of AMOTL2 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of AMOTL2 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:737053 6480464 Acrylamide results in increased expression of AMOTL2 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:737053 6480464 Aflatoxin B1 results in decreased methylation of AMOTL2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:737053 6480464 Aflatoxin B1 results in increased expression of AMOTL2 mRNA CTD PMID:27153756 alpha-pinene multiple interactions ISO RGD:737053 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of AMOTL2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of AMOTL2 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AMOTL2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of AMOTL2 mRNA CTD PMID:30779732 aristolochic acid decreases expression ISO RGD:737053 6480464 aristolochic acid I results in decreased expression of AMOTL2 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:737053 6480464 arsenite inhibits the reaction [G3BP1 protein binds to AMOTL2 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO RGD:737054 6480464 Benzo(a)pyrene results in decreased expression of AMOTL2 mRNA CTD PMID:15034205 benzo[a]pyrene affects methylation ISO RGD:737053 6480464 Benzo(a)pyrene affects the methylation of AMOTL2 3' UTR more ... CTD PMID:27901495 , PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:737053 6480464 benzo(e)pyrene results in increased methylation of AMOTL2 intron CTD PMID:30157460 bexarotene decreases expression ISO RGD:737053 6480464 bexarotene results in decreased expression of AMOTL2 mRNA CTD PMID:17178900 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AMOTL2 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AMOTL2 mRNA CTD PMID:33296240 bisphenol A multiple interactions ISO RGD:737053 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AMOTL2 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:737053 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of AMOTL2 gene CTD PMID:31601247 cadmium atom increases expression ISO RGD:737053 6480464 Cadmium results in increased expression of AMOTL2 mRNA CTD PMID:24284285 carbamazepine affects expression ISO RGD:737053 6480464 Carbamazepine affects the expression of AMOTL2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:737054 6480464 Nanotubes, Carbon results in increased expression of AMOTL2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:737053 6480464 CGP 52608 promotes the reaction [RORA protein binds to AMOTL2 gene] CTD PMID:28238834 cisplatin multiple interactions ISO RGD:737053 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of AMOTL2 mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:737053 6480464 [NSC 689534 binds to Copper] which results in increased expression of AMOTL2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:737053 6480464 [NSC 689534 binds to Copper] which results in increased expression of AMOTL2 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:737053 6480464 Copper Sulfate results in increased expression of AMOTL2 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:737053 6480464 Coumestrol results in decreased expression of AMOTL2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:737053 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:737053 6480464 Asbestos, Crocidolite results in decreased expression of AMOTL2 mRNA CTD PMID:29523930 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of AMOTL2 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:737053 6480464 Cyclosporine results in increased expression of AMOTL2 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:737053 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AMOTL2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO RGD:737054 6480464 Dibutyl Phthalate results in increased expression of AMOTL2 mRNA CTD PMID:17361019 , PMID:21266533 diuron decreases expression EXP 6480464 Diuron results in decreased expression of AMOTL2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:737053 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL2 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of AMOTL2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:737053 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA CTD PMID:19167446 fenamidone increases expression ISO RGD:737054 6480464 fenamidone results in increased expression of AMOTL2 mRNA CTD PMID:27029645 fulvestrant increases methylation ISO RGD:737053 6480464 Fulvestrant results in increased methylation of AMOTL2 gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:737053 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of AMOTL2 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AMOTL2 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO RGD:737053 6480464 Hydrogen Peroxide affects the expression of AMOTL2 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:737053 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AMOTL2 mRNA CTD PMID:28628672 leflunomide increases expression ISO RGD:737053 6480464 leflunomide results in increased expression of AMOTL2 mRNA CTD PMID:28988120 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of AMOTL2 mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Lipopolysaccharides results in increased expression of AMOTL2 mRNA] CTD PMID:16415329 menadione affects expression ISO RGD:737053 6480464 Vitamin K 3 affects the expression of AMOTL2 mRNA CTD PMID:20044591 methapyrilene increases methylation ISO RGD:737053 6480464 Methapyrilene results in increased methylation of AMOTL2 intron CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:737053 6480464 methylmercuric chloride results in increased expression of AMOTL2 mRNA CTD PMID:23179753 , PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO RGD:737053 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of AMOTL2 mRNA CTD PMID:24810058 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Lipopolysaccharides results in increased expression of AMOTL2 mRNA] CTD PMID:16415329 ochratoxin A decreases expression ISO RGD:737053 6480464 ochratoxin A results in decreased expression of AMOTL2 mRNA CTD PMID:30763683 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of AMOTL2 mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of AMOTL2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of AMOTL2 mRNA, [Topotecan co-treated with oxaliplatin] results in increased expression of AMOTL2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:737053 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of AMOTL2 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:737054 6480464 Acetaminophen affects the expression of AMOTL2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:737054 6480464 Acetaminophen results in increased expression of AMOTL2 mRNA CTD PMID:34546377 paracetamol decreases expression ISO RGD:737053 6480464 Acetaminophen results in decreased expression of AMOTL2 mRNA CTD PMID:21420995 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of AMOTL2 mRNA CTD PMID:32680482 phenylmercury acetate increases expression ISO RGD:737053 6480464 Phenylmercuric Acetate results in increased expression of AMOTL2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737053 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL2 mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO RGD:737053 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA CTD PMID:20847119 pirinixic acid increases expression ISO RGD:737054 6480464 pirinixic acid results in increased expression of AMOTL2 mRNA CTD PMID:18301758 , PMID:23811191 quercetin decreases expression ISO RGD:737053 6480464 Quercetin results in decreased expression of AMOTL2 mRNA CTD PMID:21632981 raloxifene affects expression ISO RGD:737053 6480464 Raloxifene Hydrochloride affects the expression of AMOTL2 mRNA CTD PMID:14699072 ranitidine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Lipopolysaccharides results in increased expression of AMOTL2 mRNA] CTD PMID:16415329 SB 431542 multiple interactions ISO RGD:737053 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:737053 6480464 Silicon Dioxide analog results in increased expression of AMOTL2 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:737053 6480464 Silver results in increased expression of AMOTL2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:737053 6480464 Silver results in increased expression of AMOTL2 mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:737053 6480464 sodium arsenite results in decreased expression of AMOTL2 mRNA CTD PMID:28595984 sunitinib increases expression ISO RGD:737053 6480464 Sunitinib results in increased expression of AMOTL2 mRNA CTD PMID:31533062 tert-butyl hydroperoxide multiple interactions ISO RGD:737053 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide decreases expression ISO RGD:737053 6480464 tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA CTD PMID:20847119 tetrachloromethane increases expression ISO RGD:737054 6480464 Carbon Tetrachloride results in increased expression of AMOTL2 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AMOTL2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of AMOTL2 mRNA, [Topotecan co-treated with oxaliplatin] results in increased expression of AMOTL2 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of AMOTL2 mRNA CTD PMID:25729387 triptonide increases expression ISO RGD:737054 6480464 triptonide results in increased expression of AMOTL2 mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:737053 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA more ... CTD PMID:20847119 troglitazone increases expression ISO RGD:737054 6480464 troglitazone results in increased expression of AMOTL2 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:737053 6480464 Valproic Acid affects the expression of AMOTL2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:737053 6480464 Valproic Acid results in decreased expression of AMOTL2 mRNA CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of AMOTL2 mRNA CTD PMID:19015723 vorinostat decreases expression ISO RGD:737053 6480464 vorinostat results in decreased expression of AMOTL2 mRNA CTD PMID:27188386